EE05264B1 - Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod - Google Patents

Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod

Info

Publication number: EE05264B1
Authority: EE; Estonia
Prior art keywords: prucalopride; preparation; aqueous solution; oral administration; oral
Prior art date: 1999-04-29

Application number

EEP200100539A

Other languages

English (en)

Inventor

Andr� Jos�e De Proost Eddy

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-29

Filing date

2000-04-20

Publication date

2010-02-15

2000-04-20 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2002-12-16 Publication of EE200100539A publication Critical patent/EE200100539A/et

2010-02-15 Publication of EE05264B1 publication Critical patent/EE05264B1/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EEP200100539A 1999-04-29 2000-04-20 Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod EE05264B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99201335		1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en)	1999-04-29	2000-04-20	Prucalopride oral solution

Publications (2)

Publication Number	Publication Date
EE200100539A EE200100539A (et)	2002-12-16
EE05264B1 true EE05264B1 (et)	2010-02-15

Family

ID=8240160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100539A EE05264B1 (et)	1999-04-29	2000-04-20	Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod

Country Status (36)

Country	Link
US (1)	US6413988B1 (et)
EP (1)	EP1176982B1 (et)
JP (1)	JP4773619B2 (et)
KR (1)	KR100669175B1 (et)
CN (1)	CN1165345C (et)
AR (1)	AR023815A1 (et)
AT (1)	ATE254929T1 (et)
AU (1)	AU770073B2 (et)
BG (1)	BG65061B1 (et)
BR (1)	BRPI0010150B8 (et)
CA (1)	CA2371178C (et)
CZ (1)	CZ294070B6 (et)
DE (1)	DE60006799T2 (et)
DK (1)	DK1176982T3 (et)
EA (1)	EA003904B1 (et)
EE (1)	EE05264B1 (et)
ES (1)	ES2211546T3 (et)
HK (1)	HK1045950B (et)
HR (1)	HRP20010764B1 (et)
HU (1)	HU228924B1 (et)
ID (1)	ID30397A (et)
IL (2)	IL146152A0 (et)
JO (1)	JO2181B1 (et)
MX (1)	MXPA01010953A (et)
MY (1)	MY119880A (et)
NO (1)	NO331448B1 (et)
NZ (1)	NZ515119A (et)
PL (1)	PL195674B1 (et)
PT (1)	PT1176982E (et)
SI (1)	SI1176982T1 (et)
SK (1)	SK284847B6 (et)
TR (1)	TR200103121T2 (et)
TW (1)	TW592709B (et)
UA (1)	UA68426C2 (et)
WO (1)	WO2000066170A1 (et)
ZA (1)	ZA200108820B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050063998A1 (en) *	1999-10-26	2005-03-24	Francois Marc Karel Jozef	Oral solution containing galantamine and a sweetening agent
AU2002231627A1 (en) *	2000-11-24	2002-06-03	Janssen Pharmaceutica N.V.	Use of a triple combination comprising a 5HT3 antagonist, a 5HT4 agonist and a laxative for promoting intestinal lavage
EP1467991B1 (en)	2002-01-16	2005-05-18	Janssen Pharmaceutica N.V.	Prucalopride-n-oxide
JP4526247B2 (ja) *	2002-07-08	2010-08-18	第一三共株式会社	経口用セファロスポリン製剤
FI20022007A0 (fi) *	2002-11-08	2002-11-08	Juvantia Pharma Ltd Oy	Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
ES2388501T3 (es)	2004-08-12	2012-10-16	Helsinn Healthcare S.A.	Uso de secretagogos de la hormona de crecimiento para estimular la motilidad del sistema gastrointestinal
GB201103397D0 (et)	2011-02-28	2011-04-13	Shire Movetis N V
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations
CN119700664B (zh) *	2025-02-28	2025-06-20	山东新时代药业有限公司	含有活性成分琥珀酸普芦卡必利的注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5374637A (en) *	1989-03-22	1994-12-20	Janssen Pharmaceutica N.V.	N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) *	1990-03-06	1990-05-02	Janssen Pharmaceutica Nv	N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) *	1991-12-13	1993-06-29	Kanebo Ltd	経口液剤
TW490465B (en) *	1994-11-24	2002-06-11	Janssen Pharmaceutica Nv	Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
AU770580B2 (en) *	1998-11-23	2004-02-26	Janssen Pharmaceutica N.V.	Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

2000
- 2000-04-17 TW TW089107124A patent/TW592709B/zh not_active IP Right Cessation
- 2000-04-17 JO JO200052A patent/JO2181B1/en active
- 2000-04-20 HR HR20010764A patent/HRP20010764B1/xx not_active IP Right Cessation
- 2000-04-20 DK DK00931072T patent/DK1176982T3/da active
- 2000-04-20 EP EP00931072A patent/EP1176982B1/en not_active Expired - Lifetime
- 2000-04-20 AU AU49137/00A patent/AU770073B2/en not_active Expired
- 2000-04-20 US US09/980,848 patent/US6413988B1/en not_active Expired - Lifetime
- 2000-04-20 IL IL14615200A patent/IL146152A0/xx active IP Right Grant
- 2000-04-20 SK SK1519-2001A patent/SK284847B6/sk not_active IP Right Cessation
- 2000-04-20 SI SI200030294T patent/SI1176982T1/xx unknown
- 2000-04-20 EA EA200101150A patent/EA003904B1/ru not_active IP Right Cessation
- 2000-04-20 WO PCT/EP2000/003739 patent/WO2000066170A1/en not_active Ceased
- 2000-04-20 HU HU0202324A patent/HU228924B1/hu unknown
- 2000-04-20 HK HK02107621.0A patent/HK1045950B/zh not_active IP Right Cessation
- 2000-04-20 CZ CZ20013735A patent/CZ294070B6/cs not_active IP Right Cessation
- 2000-04-20 KR KR1020017011858A patent/KR100669175B1/ko not_active Expired - Lifetime
- 2000-04-20 CN CNB008065748A patent/CN1165345C/zh not_active Expired - Lifetime
- 2000-04-20 PL PL00352062A patent/PL195674B1/pl unknown
- 2000-04-20 PT PT00931072T patent/PT1176982E/pt unknown
- 2000-04-20 BR BRPI0010150A patent/BRPI0010150B8/pt not_active IP Right Cessation
- 2000-04-20 ES ES00931072T patent/ES2211546T3/es not_active Expired - Lifetime
- 2000-04-20 NZ NZ515119A patent/NZ515119A/en not_active IP Right Cessation
- 2000-04-20 JP JP2000615054A patent/JP4773619B2/ja not_active Expired - Lifetime
- 2000-04-20 MX MXPA01010953A patent/MXPA01010953A/es active IP Right Grant
- 2000-04-20 DE DE60006799T patent/DE60006799T2/de not_active Expired - Lifetime
- 2000-04-20 ID IDW00200102322A patent/ID30397A/id unknown
- 2000-04-20 UA UA2001107369A patent/UA68426C2/uk unknown
- 2000-04-20 CA CA002371178A patent/CA2371178C/en not_active Expired - Lifetime
- 2000-04-20 AT AT00931072T patent/ATE254929T1/de active
- 2000-04-20 EE EEP200100539A patent/EE05264B1/et unknown
- 2000-04-20 TR TR2001/03121T patent/TR200103121T2/xx unknown
- 2000-04-25 MY MYPI20001765A patent/MY119880A/en unknown
- 2000-04-28 AR ARP000102075A patent/AR023815A1/es active IP Right Grant
2001
- 2001-10-02 NO NO20014794A patent/NO331448B1/no not_active IP Right Cessation
- 2001-10-19 BG BG106031A patent/BG65061B1/bg unknown
- 2001-10-25 ZA ZA200108820A patent/ZA200108820B/en unknown
- 2001-10-25 IL IL146152A patent/IL146152A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL146152A (en)	2006-12-31
JP4773619B2 (ja)	2011-09-14
MY119880A (en)	2005-07-29
JO2181B1 (en)	2003-04-23
AU4913700A (en)	2000-11-17
AU770073B2 (en)	2004-02-12
KR100669175B1 (ko)	2007-01-17
ES2211546T3 (es)	2004-07-16
DK1176982T3 (da)	2004-03-29
PT1176982E (pt)	2004-04-30
CA2371178C (en)	2008-03-25
NZ515119A (en)	2003-05-30
SK284847B6 (sk)	2006-01-05
HRP20010764A2 (en)	2002-12-31
BR0010150A (pt)	2002-01-15
EE200100539A (et)	2002-12-16
TW592709B (en)	2004-06-21
EP1176982B1 (en)	2003-11-26
MXPA01010953A (es)	2002-05-06
PL195674B1 (pl)	2007-10-31
TR200103121T2 (tr)	2002-05-21
CZ294070B6 (cs)	2004-09-15
EP1176982A1 (en)	2002-02-06
BRPI0010150B8 (pt)	2021-05-25
UA68426C2 (uk)	2004-08-16
ID30397A (id)	2001-11-29
HU228924B1 (en)	2013-06-28
IL146152A0 (en)	2002-07-25
SK15192001A3 (sk)	2002-03-05
BRPI0010150B1 (pt)	2015-06-23
BG65061B1 (bg)	2007-01-31
DE60006799T2 (de)	2004-09-23
NO20014794D0 (no)	2001-10-02
ATE254929T1 (de)	2003-12-15
CA2371178A1 (en)	2000-11-09
NO20014794L (no)	2001-10-02
HK1045950B (zh)	2005-05-27
EA200101150A1 (ru)	2002-04-25
HUP0202324A3 (en)	2003-03-28
SI1176982T1 (en)	2004-04-30
CN1348386A (zh)	2002-05-08
ZA200108820B (en)	2003-01-27
WO2000066170A1 (en)	2000-11-09
CZ20013735A3 (cs)	2002-02-13
NO331448B1 (no)	2012-01-02
BG106031A (en)	2002-05-31
HRP20010764B1 (hr)	2011-01-31
US6413988B1 (en)	2002-07-02
HUP0202324A2 (hu)	2002-12-28
AR023815A1 (es)	2002-09-04
DE60006799D1 (de)	2004-01-08
JP2002543161A (ja)	2002-12-17
HK1045950A1 (en)	2002-12-20
KR20020004972A (ko)	2002-01-16
CN1165345C (zh)	2004-09-08
PL352062A1 (en)	2003-07-28
EA003904B1 (ru)	2003-10-30

Publication	Publication Date	Title
DE69936002D1 (de)	2007-06-14	Angepasster löffel zur oralen medikamenten-verabreichung
EE04417B1 (et)	2005-02-15	Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
IL148407A0 (en)	2002-09-12	Oral pharmaceutical forms of administration with a delayed action
EE05109B1 (et)	2008-12-15	Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
PL396568A1 (pl)	2012-02-13	Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
AU9287401A (en)	2002-04-08	Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
NO20014738L (no)	2001-10-23	Tolperisonholdig farmasöytisk preparat for oral administrering
EE04490B1 (et)	2005-06-15	Ühend, selle valmistamise meetod ning kasutamine meditsiinis
PT1230230E (pt)	2003-12-31	Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
EE04954B1 (et)	2008-02-15	Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
EE05264B1 (et)	2010-02-15	Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod
EE200200199A (et)	2003-06-16	N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
DE60110666D1 (de)	2005-06-16	Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
EE04902B1 (et)	2007-10-15	Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EP1233755A4 (en)	2004-02-04	GRANULES OF MEDICINAL SALTS WITH HYDROLIZED CELLULOSE
HUP0201667A3 (en)	2003-02-28	Oral form of administration
EE05230B1 (et)	2009-12-15	Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks
EE05050B1 (et)	2008-08-15	Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks
IL150403A0 (en)	2002-12-01	NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
IL150402A0 (en)	2002-12-01	NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
EE04611B1 (et)	2006-04-17	Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina
GB9930266D0 (en)	2000-02-09	Oral administration of beneficial substances
GB0030587D0 (en)	2001-01-31	Oral administration of beneficial substances
HUP0301293A3 (en)	2004-10-28	Process for the preparation of mycophenolic acid and derivatives thereof

Legal Events

Date	Code	Title	Description
2007-08-15	GB1A	Change in the ownership or in the address of the owner
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2011-04-15	HC1A	Change of owner name